Cargando…
Use of Placental Growth Factor for Trisomy 21 Screening in Pregnancy: A Systematic Review
Background Prenatal serum screening is an important modality to screen for aneuploidy in pregnancy. The addition of placental growth factor (PLGF) to screen for trisomy 21 remains controversial. Objective To determine whether the addition of PLGF to combined serum aneuploidy screening improves det...
Autores principales: | Badeghiesh, Ahmad, Volodarsky-Perel, Alexander, Lasry, Ariane, Hemmings, Robert, Gil, Yaron, Balayla, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571571/ https://www.ncbi.nlm.nih.gov/pubmed/33094011 http://dx.doi.org/10.1055/s-0040-1713785 |
Ejemplares similares
-
Bayes Theorem and Protopathic Bias: Methodological Concerns When Addressing the Impact of Fetal Heart Rate Patterns on the Cesarean Section Rate
por: Balayla, Jacques, et al.
Publicado: (2020) -
Cell‐free DNA testing in a trisomy 21 pregnancy with confined placental mosaicism for a cell line with trisomy for both chromosomes 18 and 21
por: Crooks, Kristy, et al.
Publicado: (2015) -
Apoptosis versus necrosis in tubal ectopic pregnancies following Methotrexate
por: Gil, Yaron, et al.
Publicado: (2023) -
Two cases of placental trisomy 21 mosaicism causing false-negative NIPT results
por: Zhao, Qinfei, et al.
Publicado: (2023) -
Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring
por: Chen, Yiming, et al.
Publicado: (2023)